查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1961007

人工智慧（AI）在遠端患者監護市場的應用：市場洞察、競爭格局及至2034年的市場預測

Artificial Intelligence (AI) in Remote Patient Monitoring Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

遠端患者監護人工智慧（AI）市場概述

  • 全球遠端患者監護人工智慧市場規模預計將從 2025 年的 195.2651 億美元成長到 2034 年的 131.268 億美元，展現出強勁且持續的成長勢頭。
  • 全球遠端患者監護人工智慧市場預計在 2026 年至 2034 年的預測期內將以 27.13% 的複合年成長率成長。
  • 人工智慧在遠端患者監護市場的主要促進因素是慢性病日益普遍、遠端醫療和數位醫療保健解決方案的日益普及、穿戴式和基於物聯網的醫療設備的進步，以及製藥公司和醫療設備製造商之間日益增多的研究合作和夥伴關係活動。
  • 遠端患者監護人工智慧市場的主要企業包括美敦力、iRhythm Inc.、英國皇家飛利浦、西門子醫療、GE醫療、蘋果、alivecor Inc.、Biofourmis、Optum, Inc.、Headspace Health、Withings、NeuroRPM Inc.、Caretaker Medical、Implicity、Headspace Health、Withings、NeuroRPM Inc.、Caretaker Medical、Implicity、Skerspace Healths、Zkerpa、Caipa.Atry、Atrys、Spaypa.Atry、Caipa.
  • 預計到2025年，北美地區將引領全球人工智慧遠端患者監護市場。這一主導地位歸功於幾個關鍵因素，包括癌症和心血管疾病等慢性病的日益增多、完善的醫療基礎設施、數位醫療技術的廣泛應用以及政府的支持性政策。此外，對數位醫療的大量投資，以及穿戴式和互聯醫療設備的日益普及，預計將進一步增強該地區採用人工智慧遠端患者監護解決方案的能力，從而推動北美人工智慧遠端患者監護市場在2026年至2034年預測期內的成長。
  • 在遠端患者監護人工智慧市場的產品類型細分市場中，預計到 2025 年，設備類別將佔據最大的市場佔有率。

推動人工智慧（AI）在遠端患者監護市場成長的因素

  • 慢性病發病率上升推動人工智慧在遠端患者監護中的應用：糖尿病、心血管疾病、高血壓和慢性阻塞性肺病等慢性疾病在全球範圍內日益加重，是人工智慧在遠距患者監護領域應用的主要驅動力。人工智慧演算法的持續監測能夠及早發現併發症並進行主動疾病管理。人工智慧模型分析大量健康數據，預測病情加重和醫療緊急情況，進而減少患者再次入院，改善治療效果。
  • 遠端醫療和數位醫療解決方案的普及：受新冠疫情的進一步加速，遠端醫療和虛擬照護的普及顯著促進了人工智慧在遠距病患監護（RPM）中的應用。人工智慧技術透過提供即時患者分析、自動警報和遠距離診斷，增強了遠端醫療平台的功能。這種整合確保了病人參與的提高，並保證了在傳統醫院環境之外的醫療服務的連續性。
  • 穿戴式和物聯網醫療設備的進步：智慧型穿戴裝置和連網健康設備（例如心電圖監測儀、血糖值追蹤器和生物感測器）的普及，正在產生大量的患者數據。人工智慧在解讀這些數據、識別異常模式和提供臨床見解方面發揮關鍵作用。物聯網設備的日益精準和經濟實惠，使得人工智慧驅動的遠端患者監護解決方案更具擴充性。

人工智慧（AI）在遠端患者監護市場細分中的應用

本報告全面概​​述了遠端患者監護人工智慧 (AI) 市場，重點介紹了關鍵趨勢、成長要素、挑戰和機會。報告按產品/服務（設備、軟體、服務）、應用（心血管疾病、糖尿病、神經系統疾病等）、最終用戶（醫院/診所、診斷中心和居家醫療機構）以及地區進行了詳細的市場細分。本報告深入分析了北美、歐洲和亞太地區等主要市場的競爭格局、監管環境和市場動態，並詳細介紹了主要行業參與企業和近期產品創新，為企業提供所需數據，以識別市場潛力、制定戰略計劃，並在快速成長的遠端患者監護人工智慧市場中把握新機遇。

遠端患者監護（RPM）中的人工智慧（AI）是指將人工智慧技術整合到遠端醫療監護系統中，以便在傳統臨床環境之外持續追蹤、分析和解讀患者的健康數據。透過利用機器學習、預測分析和其他人工智慧演算法，這些系統可以檢測異常情況、預測潛在的健康風險，並為醫療服務提供者提供即時、可操作的見解。這有助於主動管理慢性疾病、實現個人化照護並改善患者預後，同時減少住院次數和醫療成本。

由於癌症、心血管疾病和文明病等慢性病的發生率不斷上升，人工智慧（AI）在遠端患者監護（RPM）領域的市場正經歷強勁成長。產品研發舉措的激增、全球對數位醫療基礎設施投資的增加以及對預防性和數據驅動型醫療保健日益成長的重視，進一步推動了這一成長。預計這些因素將在2026年至2034年的預測期內顯著擴張人工智慧驅動的遠端患者監護市場。

遠端患者監護領域人工智慧（AI）的最新市場動態和趨勢

近年來，全球遠端患者監護人工智慧市場經歷了顯著成長，這主要是由於癌症、糖尿病、心血管疾病、呼吸系統疾病等慢性病的盛行率不斷上升。此外，製藥、生物技術和醫療設備製造商之間策略聯盟和夥伴關係的日益增多，也對加速採用人工智慧遠端患者監護設備起到了關鍵作用。

人工智慧（AI）在遠端患者監護市場細分分析

人工智慧 (AI) 在遠端患者監護市場中的應用，按產品/服務（設備、軟體、服務）、應用（心血管疾病、糖尿病、神經系統疾病、其他）、最終用戶（醫院/診所、診斷中心、居家醫療機構）和地區（北美、歐洲、亞太地區、世界其他地區）分類。

遠端患者監護市場人工智慧（AI）區域分析

北美遠端患者監護市場人工智慧（AI）發展趨勢

預計2025年，北美將主導人工智慧在臨床試驗領域的市場，約佔全球總量的47%。該地區人工智慧遠端患者監護市場的成長受多種因素驅動，包括癌症和心血管疾病等慢性病患病率的上升、完善的醫療基礎設施、數位醫療技術的廣泛應用以及政府的支持性政策。此外，數位醫療舉措的巨額投資，以及穿戴式和連網醫療設備的日益普及，進一步增強了該地區採用人工智慧遠距患者監護解決方案的準備。

根據美國心臟協會（2024年）的數據，美國約有970萬成年人患有未確診的糖尿病。另有1.159億人被報告為糖尿病前期患者。

此外，美國疾病管制與預防中心（CDC，2024）報告稱，美國約有620萬成年人患有心臟衰竭。該機構也指出，約有2050萬人患有心臟疾病。此外，同年估計有650萬40歲及以上的人被診斷出患有周邊動脈疾病（PAD）。

慢性疾病患者需要頻繁監測血糖值、心率、血壓和心電圖等參數，而所有這些參數都可以透過整合人工智慧的遠端患者管理 (RPM) 設備進行有效追蹤。人工智慧演算法分析即時病患數據，偵測異常情況，預測潛在併發症，並及時向醫護人員發出警報，從而降低住院率並改善病患預後。例如，人工智慧驅動的連續血糖監測儀 (CGM) 和智慧心臟貼片正在幫助臨床醫生遠端做出明智的治療決策。隨著醫療保健系統向預防性和個人化護理轉型，人工智慧驅動的 RPM 解決方案能夠對糖尿病和心血管疾病進行持續、預測性和經濟高效的管理，這正在推動其普及和整體市場成長。

此外，北美主要的產業參與企業正積極進行產品研發活動。例如，PanopticAI 於 2025 年 1 月獲得 FDA核准，其創新的「Vital Signs」應用程式正式上市，這標誌著人工智慧驅動的遠端患者監護取得了重大突破。該應用程式作為一款醫療設備(SaMD)，利用 iPhone 和 iPad 的內藏相機，透過遠端光電容積脈搏波描記法 (rPPG) 技術提供非接觸式脈搏測量。這項突破性技術使用戶和醫療保健提供者無需物理接觸或佩戴穿戴式設備即可準確測量生命徵象，使其成為遠端醫療、慢性病管理和遠距照護應用的理想選擇。 FDA 的核准表明，基於攝影機的人工智慧健康監測工具正日益被接受，提高了病患監測系統的可及性、便利性和擴充性，尤其是在家庭和門診環境中。

因此，上述所有因素預計將在預測期內（即 2026-2034 年）推動人工智慧在遠端患者監護市場實現顯著成長。

歐洲遠端患者監護市場人工智慧（AI）趨勢

受數位化醫療轉型、人口老化以及糖尿病、心血管疾病和呼吸系統疾病等慢性病日益增多的推動，歐洲遠端患者監護（RPM）人工智慧（AI）市場正經歷強勁成長。歐洲醫療系統正在加速採用人工智慧驅動的監護工具，以實現主動式和持續性護理，尤其是在居家醫療和遠距遠端醫療環境中。歐盟的扶持政策，例如歐盟健康計畫（EU4Health）和數位歐洲計劃（Digital Europe），正在推動先進人工智慧技術的應用，以提高醫療效率並減輕醫院基礎設施的壓力。此外，基於人工智慧的RPM解決方案正在幫助醫療服務提供者分析即時患者數據，及早發現病情惡化徵兆，並制定個人化治療方案，從而改善臨床療效並降低成本。

這一趨勢的一個顯著例證是西門子醫療於2025年7月在歐洲醫院部署的人工智慧遠端患者監護平台。該平台旨在利用預測分析和持續的數據洞察，及早發現心血管和呼吸系統疾病的徵兆。這項進展表明，歐洲正在迅速採用人工智慧驅動的醫療創新技術，以改善患者預後並提高營運效率。此外，德國、英國和法國等國家在數位化醫療的推廣應用方面發揮著主導作用，這得益於其國家數位化策略和促進遠距監護技術應用的報銷機制。隨著歐洲各地的醫療系統不斷向價值醫療轉型，人工智慧與遠端患者監護的融合有望成為該地區現代醫療服務的基礎。

亞太地區遠端患者監護市場人工智慧（AI）發展趨勢

遠端患者監護人工智慧（AI）市場的主要參與企業有哪些？

以下列出了遠端患者監護人工智慧市場的主要企業，它們合計佔據最大的市場佔有率，並主導行業趨勢：

  • Medtronic
  • iRhythm Inc.
  • Koninklijke Philips NV
  • Siemens Healthineers
  • GE Healthcare
  • Apple Inc.
  • Alivecor Inc.
  • Biofourmis
  • Optum, Inc.
  • Headspace Health
  • Withings
  • NeuroRPM Inc.
  • Caretaker Medical
  • Implicity
  • Stryker
  • Biobeat
  • Zingage
  • Teton.ai
  • Athelas
  • Empatica
  • 其他

遠端患者監護人工智慧市場的競爭格局如何？

遠端患者監護(RPM) 領域的人工智慧競爭格局正逐漸演變為一個中等集中度的市場。少數幾家大型醫療技術公司（例如飛利浦、美敦力、西門子醫療、通用電氣醫療、雅培和波士頓科學）提供種類繁多的平台和設備，而充滿活力的專業Start-Ups和軟體供應商則專注於細分領域的人工智慧功能（例如癲癇發作檢測、非接觸式生命徵象監測、動態血糖監測分析和心電圖解），從而解釋了一個雙層市場解釋。大型企業憑藉其規模、監管經驗和整合產品系列，贏得醫院和保險公司的合約。然而，它們面臨著來自小規模、更靈活的公司的快速創新，這些公司提供一流的人工智慧演算法和設備整合方案，迫使它們尋求夥伴關係、OEM 協議和白牌，而不是純粹依靠自身發展。市場報告指出，市場正在快速擴張，複合年成長率 (CAGR) 預計也將很高，這吸引了策略買家和投資者，並鞏固了資金雄厚的現有企業的優勢。同時，客戶對端到端解決方案的需求以及少數幾家高度互通性供應商之間的整合趨勢，正在推動併購和平台整合，加劇市場集中度。雖然這一趨勢在演算法準確性、邊緣處理和可解釋性等技術創新領域催生了良性競爭，但也造成了一種商業性權力集中在少數幾家企業手中的格局，這些企業控制著分銷網路、電子健康記錄整合和醫保報銷關係。監管的複雜性、數據整合的負擔以及臨床檢驗的需求構成了有利於大型企業的障礙，但敏捷的Start-Ups仍在不斷贏得臨床試驗和智慧財產權許可協議，從而保持著生態系統的創新性和競爭力。

人工智慧（AI）在遠端患者監護市場的最新發展趨勢

  • 2025 年 9 月，羅氏宣布其 Accu-Chek SmartGuide CGM 系統和 mySugr 應用程式整合已獲得 CE 標誌批准，該系統整合了預測性 AI 演算法，可提供長達兩小時的血糖值預測和長達七小時的夜間血糖預測。
  • 2025 年 6 月，德克薩斯州韋伯縣布魯尼市引入了 OnMed CareStation遠端醫療服務終端，使偏遠地區的居民能夠在線上諮詢認證的醫療保健專業人員，並獲得即時健康評估，這表明數位醫療保健正在從診所擴展到服務不足的地區。
  • 2025 年 5 月，Tenovi LLC 推出了一款可與 RPM 平台（用於預防中風/心血管風險管理）配合使用的聯網血壓監測儀，該監測儀具有心律不整檢測功能。
  • 2025 年 4 月，Dexcom G7 15 天連續血糖監測系統獲得美國食品藥物管理局(FDA)核准，可用於糖尿病成人患者，允許延長佩戴時間，並提供更豐富的數據流，以便進行下游基於人工智慧的監測分析。
  • 2025 年 1 月，Glooko 宣布其妊娠糖尿病遠距監測平台 Glooko XT 已獲得法國高級衛生管理局 (HAS) 和醫療設備及醫療技術評估委員會 (CNEDiMTS) 的報銷核准。
  • 2025年1月，PanopticAI的創新「生命徵象」應用程式獲得FDA核准，標誌著人工智慧驅動的遠端患者監護領域取得了重大突破。該應用程式作為醫療設備（SaMD），利用iPhone和iPad的內藏相機，採用遠端光電容積脈搏波描記法（rPPG）技術提供非接觸式脈搏測量。
  • BioButton 多重病人穿戴式裝置和 BioDashboard 系統於 2024 年 10 月獲得美國食品藥物管理局(FDA) 的核准。此穿戴式裝置利用人工智慧分析技術，可在家庭環境中進行遠端監測。
  • 2023 年 3 月，NeuroRPM 的革命性應用 NeuroRPM Apple Watch 獲得了 FDA 的批准，這是一款突破性的 AI 解決方案，用於遠端監測帕金森氏症患者的運動症狀（例如運動遲緩、震顫和運動障礙）。

遠端患者監護市場中人工智慧（AI）的市場細分

影響分析

人工智慧驅動的創新與應用：

人工智慧驅動的遠端患者監護(RPM) 創新和應用正在徹底改變患者資料的即時收集、分析和應用方式。這些創新包括先進的機器學習演算法和預測分析，用於早期檢測健康狀況惡化，例如心率、血糖值和呼吸模式的變化，從而實現及時的醫療干預。人工智慧驅動的穿戴式設備和非接觸式設備，例如智慧型手錶、生物識別感測器和基於攝影機的系統，持續追蹤生命徵象，而自然語言處理 (NLP) 和聊天機器人則增強了患者參與度和醫護人員之間的溝通。此外，電腦視覺技術分析面部表情和膚色以評估血氧飽和度和壓力水平，數位雙胞胎技術模擬個體健康狀況以預測疾病進展。基於雲端的人工智慧系統進一步整合來自不同來源的多模態數據，並透過自動化儀表板為臨床醫生提供可操作的見解。總而言之，這些由人工智慧驅動的應用正在將遠距監護轉變為領先、個人化和高效的醫療保健模式，從而減少患者再入院率並改善患者預後。

美國關稅對遠端患者監護人工智慧（AI）市場的影響分析：

美國對人工智慧遠距遠端患者監護徵收關稅的影響主要體現在這些系統所需關鍵組件和技術的進口成本增加。許多人工智慧遠端監護設備，包括感測器、穿戴式組件、半導體和通訊模組，都來自中國大陸、台灣和韓國等國家和地區。對這些進口產品徵收關稅可能會增加美國製造商的生產和採購成本，減緩醫療機構的創新和應用速度。此外，對用於整合人工智慧的雲端基礎設施硬體和資料處理設備徵收關稅，可能會進一步加劇營運預算的壓力。然而，這些挑戰也推動了美國本土人工智慧和數位醫療Start-Ups的生產和投資，促進了本地製造業和軟體開發的創新。總而言之，雖然關稅會增加短期成本並增加供應鏈的複雜性，但它們也刺激了旨在加強國內人工智慧醫療技術生態系統的長期策略性舉措。

目錄

第1章遠端患者監護市場中的人工智慧（AI）簡介

第2章遠端患者監護市場人工智慧（AI）市場執行摘要

  • 市場概覽

第3章遠端患者監護市場人工智慧（AI）關鍵因素分析

  • 遠端患者監護市場促進因素
  • 遠端患者監護市場限制與挑戰
  • 人工智慧（AI）在遠端患者監護的市場機遇

第4章 影響分析

  • 人工智慧驅動的創新和應用
  • 美國關稅的影響分析

第5章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章 人工智慧（AI）在遠端患者監護市場的應用：波特五力分析

第7章遠端患者監護人工智慧（AI）市場評估

  • 按產品/服務
    • 裝置
    • 軟體
    • 服務
  • 透過使用
    • 心血管疾病
    • 糖尿病
    • 神經系統疾病
    • 其他
  • 最終用戶
    • 醫院和診所
    • 診斷中心
    • 居家照護
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 競爭情勢

第9章Start-Ups資金籌措與投資趨勢

第10章遠端患者監護市場人工智慧（AI）公司及產品概況

  • Medtronic
  • iRhythm Inc.
  • Koninklijke Philips NV
  • Siemens Healthineers
  • GE HealthCare
  • Apple Inc.
  • Alivecor Inc.
  • Biofourmis
  • Optum, Inc.
  • Headspace Health
  • Withings
  • NeuroRPM Inc.
  • Caretaker Medical
  • Implicity
  • Stryker
  • Biobeat
  • Zingage
  • Teton.ai
  • Athelas
  • Empatica

第11章：KOL視角

第12章計劃方法

第13章：關於 DelveInsight

第14章 免責聲明和聯絡我們

Product Code: DIMDCL0866

Artificial Intelligence (AI) in Remote Patient Monitoring Market Summary

  • The global artificial intelligence in remote patient monitoring market is expected to increase from USD 1,9526.51 million in 2025 to USD 13,126.80 million by 2034, reflecting strong and sustained growth.
  • The global artificial intelligence in remote patient monitoring market is growing at a CAGR of 27.13% during the forecast period from 2026 to 2034.
  • The market of artificial intelligence in remote patient monitoring is being primarily driven by the growing prevalence of chronic diseases, increasing adoption of telehealth and digital healthcare solutions, advancements in wearable and IoT-based medical devices, and increasing research collaboration and partnership activities among pharma and medical device companies.
  • The leading companies operating in the artificial intelligence in remote patient monitoring market include Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., alivecor Inc., Biofourmis, Optum, Inc., Headspace Health, Withings, NeuroRPM Inc., Caretaker Medical, Implicity, Stryker, Biobeat, Zingage, Teton.ai, Athelas, Empatica, and others.
  • North America is expected to dominate the overall artificial intelligence in remote patient monitoring market in 2025. This dominance can be attributed to several key factors, including the rising prevalence of chronic diseases such as cancer and cardiovascular disorders, a robust healthcare infrastructure, widespread adoption of digital health technologies, and supportive government policies. Additionally, the substantial investments in digital health initiatives, coupled with the increasing adoption of wearable and connected medical devices, have further strengthened the region's readiness for AI-enabled RPM solutions, ultimately contributing to the growth of the AI in remote patient monitoring market in North America during the forecast period from 2026 to 2034.
  • In the product type segment of the artificial intelligence in remote patient monitoring market, the devices category is estimated to account for the largest market share in 2025.

Factors Contributing to the Growth of the Artificial Intelligence (AI) in Remote Patient Monitoring Market

  • Growing prevalence of chronic diseases leading to a surge in artificial intelligence in remote patient monitoring: The growing global burden of chronic conditions such as diabetes, cardiovascular diseases, hypertension, and COPD is a key driver for AI in RPM. Continuous monitoring enabled by AI algorithms allows early detection of complications and proactive disease management. AI models analyze large amounts of health data to predict exacerbations or medical emergencies, thereby reducing hospital readmissions and improving outcomes.
  • Increasing adoption of telehealth and digital healthcare solutions: The shift toward telemedicine and virtual healthcare, accelerated more by the COVID-19 pandemic, has significantly boosted the adoption of AI in RPM. AI technologies enhance the capabilities of telehealth platforms by providing real-time patient analytics, automated alerts, and remote diagnostics. This integration ensures better patient engagement and continuity of care beyond traditional hospital settings.
  • Advancements in wearable and IoT-based medical devices: The proliferation of smart wearables and connected health devices, such as ECG monitors, glucose trackers, and biosensors, generates vast amounts of patient data. AI plays a critical role in interpreting this data, identifying abnormal patterns, and offering clinical insights. The increasing accuracy and affordability of IoT-enabled devices are enhancing the scalability of AI-driven remote patient monitoring solutions.

Artificial Intelligence (AI) in Remote Patient Monitoring Market Report Segmentation

This artificial intelligence in remote patient monitoring market report offers a comprehensive overview of the global artificial intelligence in remote patient monitoring market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product & Services (Devices, Software, and Services), Application (Cardiovascular Disorder, Diabetes, Neurological Disorders, and Others), End-Users (Hospitals & Clinics, Diagnostic Centers, and Homecare Setting), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing artificial intelligence in remote patient monitoring market.

Artificial Intelligence (AI) in Remote Patient Monitoring (RPM) refers to the integration of AI technologies with remote healthcare monitoring systems to continuously track, analyze, and interpret patient health data outside traditional clinical settings. By leveraging machine learning, predictive analytics, and other AI algorithms, these systems can detect anomalies, predict potential health risks, and provide actionable insights to healthcare providers in real time. This enables proactive management of chronic conditions, personalized care, and improved patient outcomes while reducing hospital visits and healthcare costs.

The Artificial Intelligence (AI) in remote patient monitoring (RPM) market is experiencing robust growth, fueled by the rising cases of chronic conditions such as cancer, cardiovascular diseases, and lifestyle-related disorders. This growth is further supported by a surge in product development initiatives, increasing global investments in digital health infrastructure, and a growing emphasis on proactive, data-driven healthcare. These factors are expected to drive significant expansion of the AI-powered remote patient monitoring market during the forecast period from 2026 to 2034.

What are the latest Artificial Intelligence (AI) in Remote Patient Monitoring market dynamics and trends?

The global market for artificial intelligence in remote patient monitoring has witnessed significant growth in recent years, largely driven by the increasing prevalence of chronic disorders such as cancer, diabetes, cardiovascular disorders, and respiratory conditions. Additionally, the growing trend of strategic collaborations and partnerships among pharmaceutical, biotechnology, and medical device companies is playing a crucial role in accelerating the adoption of AI-powered remote patient monitoring devices.

Artificial Intelligence (AI) in Remote Patient Monitoring Market Segment Analysis

Artificial Intelligence (AI) in Remote Patient Monitoring Market by Product & Services (Devices, Software, and Services), Application (Cardiovascular Disorder, Diabetes, Neurological Disorders, and Others), End-Users (Hospitals & Clinics, Diagnostic Centers, and Homecare Setting), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Artificial Intelligence (AI) in Remote Patient Monitoring Market Regional Analysis

North America Artificial Intelligence (AI) in Remote Patient Monitoring Market Trends

North America is projected to dominate the AI in clinical trial market in 2025, accounting for approximately 47% of the total share. The growth of the Artificial Intelligence (AI) in remote patient monitoring market in the region is being driven by a combination of factors, including the rising prevalence of chronic diseases such as cancer and cardiovascular disorders, a robust healthcare infrastructure, widespread adoption of digital health technologies, and supportive government policies. Additionally, the substantial investments in digital health initiatives, coupled with the increasing adoption of wearable and connected medical devices, have further strengthened the region's readiness for AI-enabled RPM solutions.

According to the American Heart Association (2024), approximately 9.7 million adults were living with undiagnosed diabetes in the United States. Furthermore, 115.9 million people in the U.S were reported to be dealing with pre-diabetes.

Additionally, according to an article published by the CDC (2024), approximately 6.2 million adults were suffering from heart failure in the US. The same source further stated that around 20.5 million individuals were living with coronary heart disease. Furthermore, an estimated 6.5 million individuals aged 40 and older were diagnosed with peripheral artery disease (PAD) in the same year.

Patients with these chronic conditions require frequent monitoring of parameters such as blood glucose levels, heart rate, blood pressure, and ECG data, all of which can be effectively tracked using AI-integrated RPM devices. AI algorithms analyze real-time patient data to detect anomalies, predict potential complications, and provide timely alerts to healthcare providers, thereby reducing hospitalizations and improving patient outcomes. For instance, AI-enabled continuous glucose monitors (CGMs) and smart cardiac patches are helping clinicians make informed treatment decisions remotely. As healthcare systems shift toward preventive and personalized care, the ability of AI-driven RPM solutions to offer continuous, predictive, and cost-efficient management for diabetes and cardiovascular diseases is fueling their widespread adoption and propelling overall market growth.

Moreover, leading industry players in North America are actively involved in product development activities. For example, in January 2025, PanopticAI received FDA clearance for its innovative "Vital Signs" app, marking a major advancement in AI-powered remote patient monitoring. The app functions as a Software as a Medical Device (SaMD) and leverages the built-in camera of iPhones and iPads to perform contactless pulse rate measurement using remote photoplethysmography (rPPG) technology. This breakthrough enables users and healthcare providers to measure vital signs accurately without the need for physical contact or wearable devices, making it ideal for telehealth, chronic disease management, and remote care applications. The FDA approval highlights the growing acceptance of AI-driven, camera-based health monitoring tools, which enhance accessibility, convenience, and scalability in patient monitoring systems, particularly in home and outpatient settings.

Hence, all the above-mentioned factors are anticipated to register significant growth during the forecast period from 2026 to 2034 in the AI in remote patient monitoring market.

Europe Artificial Intelligence (AI) in Remote Patient Monitoring Market Trends

The Artificial Intelligence (AI) in Remote Patient Monitoring (RPM) market in Europe is witnessing robust growth, fueled by the region's strong emphasis on digital healthcare transformation, aging population, and rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory conditions. European healthcare systems are increasingly integrating AI-driven monitoring tools to enable proactive and continuous care delivery, particularly within home healthcare and telemedicine settings. The European Union's supportive policies, such as the EU4Health Program and Digital Europe initiatives, are fostering the adoption of advanced AI technologies to enhance healthcare efficiency and reduce the burden on hospital infrastructure. Moreover, AI-based RPM solutions are helping healthcare providers analyze real-time patient data, detect early signs of deterioration, and personalize treatment plans, leading to better clinical outcomes and cost savings.

A notable example underscoring this trend came in July 2025, when Siemens Healthineers launched its AI-powered remote patient monitoring platform across European hospitals, designed to detect early signs of cardiovascular and respiratory distress using predictive analytics and continuous data insights. This development demonstrates how Europe is rapidly embracing AI-enabled healthcare innovations to improve patient outcomes and operational efficiency. Additionally, countries like Germany, the UK, and France are leading in digital health adoption, supported by national digitalization strategies and reimbursement frameworks that encourage the use of remote monitoring technologies. As healthcare systems across Europe continue to transition toward value-based care, the integration of AI in remote patient monitoring is expected to become a cornerstone of modern healthcare delivery in the region.

Asia-Pacific Artificial Intelligence (AI) in Remote Patient Monitoring Market Trends

Who are the major players in the Artificial Intelligence (AI) in Remote Patient Monitoring market?

The following are the leading companies in the artificial intelligence in remote patient monitoring market. These companies collectively hold the largest market share and dictate industry trends.

  • Medtronic
  • iRhythm Inc.
  • Koninklijke Philips N.V.
  • Siemens Healthineers
  • GE Healthcare
  • Apple Inc.
  • Alivecor Inc.
  • Biofourmis
  • Optum, Inc.
  • Headspace Health
  • Withings
  • NeuroRPM Inc.
  • Caretaker Medical
  • Implicity
  • Stryker
  • Biobeat
  • Zingage
  • Teton.ai
  • Athelas
  • Empatica
  • Others

How is the competitive landscape shaping the artificial intelligence in remote patient monitoring market?

The competitive landscape for AI in Remote Patient Monitoring (RPM) is evolving into a moderately concentrated market: a handful of large medtech incumbents (Philips, Medtronic, Siemens Healthineers, GE Health Care, Abbott, Boston Scientific, etc.) lead broad platform and device offerings, while a vibrant set of specialized startups and software vendors focus on niche AI capabilities (seizure detection, contactless vitals, CGM analytics, ECG interpretation), creating a two-tier market structure. Major established players leverage scale, regulatory experience, and integrated product portfolios to win hospital and payer contracts, but they face fast innovation coming from smaller, agile firms that supply best-in-class AI algorithms and device integrations, forcing partnerships, OEM deals, and white-labeling rather than purely organic expansion. Market reports show rapid market expansion and strong projected CAGRs, which attract both strategic buyers and investors and reinforce the dominance of well-funded incumbents. At the same time, deal activity and consolidation are rising as customers demand end-to-end solutions and fewer, more interoperable vendors driving M&A and platform rollups that increase concentration over time. This dynamic produces healthy competition on innovation (algorithm accuracy, edge processing, explainability) while concentrating commercial power among a moderate number of integrators who control distribution, EHR integrations, and reimbursement relationships. Regulatory complexity, data-integration burdens, and the need for clinical validation create barriers that advantage larger firms, but nimble startups continue to win clinical pilots and IP licensing deals, keeping the ecosystem innovative and contested.

Recent Developmental Activities in the Artificial Intelligence (AI) in Remote Patient Monitoring Market

  • In September 2025, Roche announced CE-mark approval for the integration of its Accu-Chek SmartGuide CGM system with its mySugr app, incorporating predictive AI algorithms that forecast glucose levels up to two hours ahead and overnight for up to seven hours.
  • In June 2025, Bruni, Texas, in Webb County, launched an OnMed CareStation telehealth kiosk that enables residents in a remote community to consult virtually with licensed clinicians and undergo real-time health assessments, thereby illustrating how digital care is extending beyond clinics into underserved areas.
  • In May 2025, Tenovi LLC launched a connected blood pressure monitor integrated with their RPM platform (for stroke prevention / cardiovascular risk) with irregular heartbeat detection.
  • In April 2025, the Dexcom G7 15-Day Continuous Glucose Monitoring System was cleared by the U.S. Food and Drug Administration (FDA) for adults with diabetes, enhancing wear time and enabling richer data streams for downstream AI-based monitoring analytics.
  • In January 2025, Glooko, Inc. announced that the Glooko XT platform (remote monitoring of gestational diabetes) obtained reimbursement approval in France via the Haute Autorite de Sante (HAS) / Commission Nationale d'Evaluation des Dispositifs Medicaux et des Technologies de Sante (CNEDiMTS).
  • In January 2025, PanopticAI received FDA clearance for its innovative "Vital Signs" app, marking a major advancement in AI-powered remote patient monitoring. The app functions as a Software as a Medical Device (SaMD) and leverages the built-in camera of iPhones and iPads to perform contactless pulse rate measurement using remote photoplethysmography (rPPG) technology.
  • In October 2024, the BioButton Multi-Patient wearable + BioDashboard system received US Food and Drug Administration (FDA) approval. This wearable device extends remote monitoring into home settings supported by AI analytics.
  • In March 2023, NeuroRPM Inc. received FDA clearance for its innovative NeuroRPM Apple Watch application, a groundbreaking AI-powered solution designed to remotely monitor key motor symptoms in patients with Parkinson's disease, including bradykinesia, tremor, and dyskinesia.

Artificial Intelligence (AI) in Remote Patient Monitoring Market Segmentation

  • Artificial Intelligence (AI) in Remote Patient Monitoring by Product & Services Exposure
  • Devices
  • Software
  • Services
  • Artificial Intelligence (AI) in Remote Patient Monitoring Application Exposure
  • Cardiovascular Disorder
  • Diabetes
  • Neurological Disorders
  • Others
  • Artificial Intelligence (AI) in Remote Patient Monitoring End-Users Exposure
  • Hospitals and Clinics
  • Diagnostic Centers
  • Homecare Settings
  • Artificial Intelligence (AI) in Remote Patient Monitoring Geography Exposure
  • North America Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • United States Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Canada Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Mexico Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Europe Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • United Kingdom Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Germany Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • France Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Italy Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Spain Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Rest of Europe Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Asia-Pacific Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • China Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Japan Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • India Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Australia Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • South Korea Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Rest of Asia-Pacific Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Rest of the World Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • South America Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Middle East Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Africa Artificial Intelligence (AI) in Remote Patient Monitoring Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations and applications in AI-enabled remote patient monitoring (RPM) are revolutionizing how patient data is collected, analyzed, and acted upon in real time. These innovations include advanced machine learning algorithms and predictive analytics that enable early detection of health deterioration, such as changes in heart rate, glucose levels, or respiratory patterns, allowing timely medical intervention. AI-powered wearable and non-contact devices like smartwatches, biosensors, and camera-based systems-continuously track vital signs, while natural language processing (NLP) and chatbots enhance patient engagement and communication between patients and healthcare providers. Additionally, computer vision technologies analyze facial cues and skin tone to assess oxygen saturation or stress, while digital twins simulate individual health profiles to predict disease progression. Cloud-based AI systems further integrate multi-modal data from diverse sources, offering clinicians actionable insights through automated dashboards. Collectively, these AI-driven applications are transforming remote monitoring into a proactive, personalized, and efficient healthcare model that reduces hospital readmissions and improves patient outcomes.

U.S. Tariff Impact Analysis on Artificial Intelligence (AI) in Remote Patient Monitoring Market:

The U.S. tariff impact on AI-enabled remote patient monitoring primarily revolves around the increased cost of importing essential components and technologies used in these systems. Many AI-powered remote monitoring devices, such as sensors, wearable components, semiconductors, and communication modules, are sourced from countries like China, Taiwan, and South Korea. Tariffs imposed on these imports can raise production and procurement costs for U.S. manufacturers, potentially slowing innovation and adoption rates in healthcare facilities. Additionally, tariffs on cloud infrastructure hardware and data processing equipment used in AI integration may further strain operational budgets. However, these challenges have also encouraged domestic production and investment in U.S.-based AI and digital health startups, driving innovation in local manufacturing and software development. Overall, while tariffs increase short-term costs and supply chain complexities, they also stimulate long-term strategic initiatives aimed at strengthening the domestic ecosystem for AI-enabled healthcare technologies.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the Artificial Intelligence (AI) in Remote Patient Monitoring market report study

  • Market size analysis for the current artificial intelligence in remote patient monitoring market size (2025), and market forecast for 8 years (2026 to 2034)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the artificial intelligence in remote patient monitoring market.
  • Various opportunities available for the other competitors in the artificial intelligence in remote patient monitoring market space.
  • What are the top-performing segments in 2025? How these segments will perform in 2034?
  • Which are the top-performing regions and countries in the current artificial intelligence in remote patient monitoring market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the artificial intelligence in remote patient monitoring market growth in the future?

Frequently Asked Questions for the Artificial Intelligence (AI) in Remote Patient Monitoring Market

1. What is the growth rate of the artificial intelligence in remote patient monitoring market?

  • The artificial intelligence in remote patient monitoring market is estimated to grow at a CAGR of 27.13% during the forecast period from 2026 to 2034.

2. What is the market for artificial intelligence in remote patient monitoring?

  • The global artificial intelligence in remote patient monitoring market is expected to increase from USD 1,9526.51 million in 2025 to USD 13,126.80 million by 2034.

3. Which region has the highest share in the artificial intelligence in remote patient monitoring market?

  • North America is expected to dominate the overall artificial intelligence in remote patient monitoring market in 2025. The growth of the Artificial Intelligence (AI) in remote patient monitoring market in the region is being driven by a combination of factors, including the rising prevalence of chronic diseases such as cancer and cardiovascular disorders, a robust healthcare infrastructure, widespread adoption of digital health technologies, and supportive government policies. Additionally, the substantial investments in digital health initiatives, coupled with the increasing adoption of wearable and connected medical devices, have further strengthened the region's readiness for AI-enabled RPM solutions.

4. What are the drivers for the artificial intelligence in remote patient monitoring market?

  • The Artificial Intelligence (AI) in remote patient monitoring (RPM) market is experiencing robust growth, fueled by the rising cases of chronic conditions such as cancer, cardiovascular diseases, and lifestyle-related disorders. This growth is further supported by a surge in product development initiatives, increasing global investments in digital health infrastructure, and a growing emphasis on proactive, data-driven healthcare. These factors are expected to drive significant expansion of the AI-powered remote patient monitoring market during the forecast period from 2026 to 2034.

5. Who are the key players operating in the Artificial Intelligence (AI) in Remote Patient Monitoring market?

  • Some of the key market players operating in the Artificial Intelligence (AI) in Remote Patient Monitoring market include Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., alivecor Inc., Biofourmis, Optum, Inc., Headspace Health, Withings, NeuroRPM Inc., Caretaker Medical, Implicity, Stryker, Biobeat, Zingage, Teton.ai, Athelas, Empatica, and others.

Table of Contents

1. Artificial Intelligence (AI) in Remote Patient Monitoring Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Artificial Intelligence (AI) in Remote Patient Monitoring Market Executive Summary

  • 2.1 Market at Glance

3. Artificial Intelligence (AI) in Remote Patient Monitoring Market Key Factors Analysis

  • 3.1 Artificial Intelligence (AI) in Remote Patient Monitoring Market Drivers
    • 3.1.1 The growing prevalence of chronic diseases
    • 3.1.2 Increasing adoption of telehealth and digital healthcare solutions
    • 3.1.3 Advancements in wearable and IoT-based medical devices
  • 3.2 Artificial Intelligence (AI) in Remote Patient Monitoring Market Restraints and Challenges
    • 3.2.1 Concerns regarding patient data & privacy
    • 3.2.2 Stringent regulations and complexities in Artificial Intelligence (AI) integration
  • 3.3 Artificial Intelligence (AI) in Remote Patient Monitoring Market Opportunity
    • 3.3.1 Strategic business partnerships between AI startups and healthcare giants

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Artificial Intelligence (AI) in Remote Patient Monitoring Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Artificial Intelligence (AI) in Remote Patient Monitoring Market Assessment

  • 7.1 By Product & Services
    • 7.1.1 Device
    • 7.1.2 Software
    • 7.1.3 Services
  • 7.2 By Application
    • 7.2.1 Cardiovascular Disorder
    • 7.2.2 Diabetes
    • 7.2.3 Neurological Disorders
    • 7.2.4 Others
  • 7.3 By End-Users
    • 7.3.1 Hospitals and Clinics
    • 7.3.2 Diagnostic Centers
    • 7.3.3 Homecare Settings
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.1.2 Canada Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.1.3 Mexico Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
    • 7.4.2 Europe
      • 7.4.2.1 France Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.2.2 Germany Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.2.3 United Kingdom Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.2.4 Italy Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.2.5 Spain Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.2.6 Rest of Europe Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.3.2 Japan Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.3.3 India Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.3.4 Australia Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.3.5 South Korea Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.3.6 Rest of Asia-Pacific Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 Middle East Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.4.2 Africa Artificial Intelligence (AI) in Remote Patient Monitoring Market Size in USD million (2023-2034)
      • 7.4.4.3 South America Artificial Intelligence (AI) in Remote Patient Monitoring Market Size In USD Million (2023-2034)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Artificial Intelligence (AI) in Remote Patient Monitoring Market Company and Product Profiles

  • 10.1 Medtronic
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 iRhythm Inc.
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Koninklijke Philips N.V.
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Siemens Healthineers
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 GE HealthCare
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Apple Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Alivecor Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Biofourmis
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Optum, Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Headspace Health
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 Withings
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 NeuroRPM Inc.
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Caretaker Medical
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 Implicity
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 Stryker
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 Biobeat
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 Zingage
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Teton.ai
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Athelas
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 Empatica
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global (2023-2034)
  • Table 2: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by Product & Services (2023-2034)
  • Table 3: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by Application (2023-2034)
  • Table 4: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by End-Users (2023-2034)
  • Table 5: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by Geography (2023-2034)
  • Table 6: Artificial Intelligence (AI) in Remote Patient Monitoring Market in North America (2023-2034)
  • Table 7: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the United States (2023-2034)
  • Table 8: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Canada (2023-2034)
  • Table 9: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Mexico (2023-2034)
  • Table 10: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Europe (2023-2034)
  • Table 11: Artificial Intelligence (AI) in Remote Patient Monitoring Market in France (2023-2034)
  • Table 12: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Germany (2023-2034)
  • Table 13: Artificial Intelligence (AI) in Remote Patient Monitoring Market in United Kingdom (2023-2034)
  • Table 14: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Italy (2023-2034)
  • Table 15: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Spain (2023-2034)
  • Table 16: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the Rest of Europe (2023-2034)
  • Table 17: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Asia-Pacific (2023-2034)
  • Table 18: Artificial Intelligence (AI) in Remote Patient Monitoring Market in China (2023-2034)
  • Table 19: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Japan (2023-2034)
  • Table 20: Artificial Intelligence (AI) in Remote Patient Monitoring Market in India (2023-2034)
  • Table 21: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Australia (2023-2034)
  • Table 22: Artificial Intelligence (AI) in Remote Patient Monitoring Market in South Korea (2023-2034)
  • Table 23: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Rest of Asia-Pacific (2023-2034)
  • Table 24: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the Rest of the World (2023-2034)
  • Table 25: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the Middle East (2023-2034)
  • Table 26: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Africa (2023-2034)
  • Table 27: Artificial Intelligence (AI) in Remote Patient Monitoring Market in South America (2023-2034)
  • Table 28: Competitive Landscape
  • Table 29: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Artificial Intelligence (AI) in Remote Patient Monitoring Market Drivers
  • Figure 2: Artificial Intelligence (AI) in Remote Patient Monitoring Market Restraints
  • Figure 3: Artificial Intelligence (AI) in Remote Patient Monitoring Market Opportunities
  • Figure 4: AI-Powered Innovations in Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Figure 5: US Tariff Impact on Artificial Intelligence (AI) in Remote Patient Monitoring Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global (2023-2034)
  • Figure 10: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by Product & Services (2023-2034)
  • Figure 11: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by Application (2023-2034)
  • Figure 12: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by End-Users (2023-2034)
  • Figure 13: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Global by Geography (2023-2034)
  • Figure 14: Artificial Intelligence (AI) in Remote Patient Monitoring Market in North America (2023-2034)
  • Figure 15: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the United States (2023-2034)
  • Figure 16: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Canada (2023-2034)
  • Figure 17: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Mexico (2023-2034)
  • Figure 18: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Europe (2023-2034)
  • Figure 19: Artificial Intelligence (AI) in Remote Patient Monitoring Market in France (2023-2034)
  • Figure 20: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Germany (2023-2034)
  • Figure 21: Artificial Intelligence (AI) in Remote Patient Monitoring Market in United Kingdom (2023-2034)
  • Figure 22: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Italy (2023-2034)
  • Figure 23: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Spain (2023-2034)
  • Figure 24: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the Rest of Europe (2023-2034)
  • Figure 25: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Asia-Pacific (2023-2034)
  • Figure 26: Artificial Intelligence (AI) in Remote Patient Monitoring Market in China (2023-2034)
  • Figure 27: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Japan (2023-2034)
  • Figure 28: Artificial Intelligence (AI) in Remote Patient Monitoring Market in India (2023-2034)
  • Figure 29: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Australia (2023-2034)
  • Figure 30: Artificial Intelligence (AI) in Remote Patient Monitoring Market in South Korea (2023-2034)
  • Figure 31: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Rest of Asia-Pacific (2023-2034)
  • Figure 32: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the Rest of the World (2023-2034)
  • Figure 33: Artificial Intelligence (AI) in Remote Patient Monitoring Market in the Middle East (2023-2034)
  • Figure 34: Artificial Intelligence (AI) in Remote Patient Monitoring Market in Africa (2023-2034)
  • Figure 35: Artificial Intelligence (AI) in Remote Patient Monitoring Market in South America (2023-2034)
  • Figure 36: Competitive Landscape
  • Figure 37: Startup Funding & Investment Trends